Intravenous Immunoglobulin in Neonatal Sepsis

Authors

  • Jiang Li School of Medicine, ZhongDa Hospital, Southeast University
  • Mahesh Kumar Gautam School of Medicine, ZhongDa Hospital, Southeast University

DOI:

https://doi.org/10.3126/jnps.v33i2.7400

Keywords:

Neonatal sepsis, Intravenous immunoglobulin

Abstract

Neonatal sepsis remains the major cause of mortality and morbidity including neurodevelopmental impairment and prolonged hospital stay in newborn infants. Despite of advances in technology and optimal antibiotic treatment, incidence of neonatal sepsis and its complications remains unacceptably high especially in developing countries. Premature neonates in particular are at higher risk due to developmentally immature host defense mechanisms. Though not approved by Food and Drug Administration (FDA) U.S.A, off label use of intravenous immunoglobulin continues in many countries. Recent evidences showed no significant decrease in the mortality rate or other outcomes when intravenous immunoglobulin is administered in addition to standard therapies. Hence, use of intravenous immunoglobulin in suspected or proven neonatal sepsis is not recommended. The expense of prophylactic use of intravenous immunoglobulin administration for both term and preterm newborn population, given the minimal benefit is not justified. Future studies are required which should focus on other prophylactic or adjuvant treatment modalities in addition to the standard therapy in neonatal sepsis. 

DOI: http://dx.doi.org/10.3126/jnps.v33i2.7400

J Nepal Paediatr Soc. 2013; 33(2):125-128

Downloads

Download data is not yet available.
Abstract
735
PDF
1330

Author Biographies

Jiang Li, School of Medicine, ZhongDa Hospital, Southeast University

Chief Paediatrician, Department of Paediatrics

Mahesh Kumar Gautam, School of Medicine, ZhongDa Hospital, Southeast University

Resident doctor, Department of Pediatrics

Downloads

Published

2013-10-07

How to Cite

Li, J., & Gautam, M. K. (2013). Intravenous Immunoglobulin in Neonatal Sepsis. Journal of Nepal Paediatric Society, 33(2), 125–128. https://doi.org/10.3126/jnps.v33i2.7400

Issue

Vol. 33 No. 2 (2013)

Section

Review Article

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).